Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. more
Time Frame | ADMA | Sector | S&P500 |
---|---|---|---|
1-Week Return | -6.21% | -2.27% | -0.57% |
1-Month Return | -13.41% | -3.96% | 1.21% |
3-Month Return | 2.76% | -9.7% | 7.57% |
6-Month Return | 72.45% | -3.37% | 11.45% |
1-Year Return | 363.59% | 3.71% | 28.48% |
3-Year Return | 1330% | 3.8% | 29.52% |
5-Year Return | 355.64% | 39.78% | 90.66% |
10-Year Return | 69.15% | 106.91% | 203.75% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 29.35M | 42.22M | 80.94M | 154.08M | 258.21M | [{"date":"2019-12-31","value":11.37,"profit":true},{"date":"2020-12-31","value":16.35,"profit":true},{"date":"2021-12-31","value":31.35,"profit":true},{"date":"2022-12-31","value":59.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 39.50M | 61.29M | 79.77M | 118.81M | 169.27M | [{"date":"2019-12-31","value":23.34,"profit":true},{"date":"2020-12-31","value":36.21,"profit":true},{"date":"2021-12-31","value":47.12,"profit":true},{"date":"2022-12-31","value":70.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (10.16M) | (19.07M) | 1.17M | 35.27M | 88.94M | [{"date":"2019-12-31","value":-11.42,"profit":false},{"date":"2020-12-31","value":-21.44,"profit":false},{"date":"2021-12-31","value":1.32,"profit":true},{"date":"2022-12-31","value":39.65,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | (34.60%) | (45.17%) | 1.45% | 22.89% | 34.44% | [{"date":"2019-12-31","value":-100.45,"profit":false},{"date":"2020-12-31","value":-131.14,"profit":false},{"date":"2021-12-31","value":4.21,"profit":true},{"date":"2022-12-31","value":66.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 31.27M | 45.84M | 59.55M | 74.63M | 66.59M | [{"date":"2019-12-31","value":41.9,"profit":true},{"date":"2020-12-31","value":61.43,"profit":true},{"date":"2021-12-31","value":79.79,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.22,"profit":true}] |
Operating Income | (41.42M) | (64.91M) | (58.37M) | (39.37M) | 21.63M | [{"date":"2019-12-31","value":-191.5,"profit":false},{"date":"2020-12-31","value":-300.09,"profit":false},{"date":"2021-12-31","value":-269.85,"profit":false},{"date":"2022-12-31","value":-181.98,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (15.05M) | (22.53M) | (26.54M) | (45.98M) | (73.41M) | [{"date":"2019-12-31","value":-1504758400,"profit":false},{"date":"2020-12-31","value":-2253061100,"profit":false},{"date":"2021-12-31","value":-2653550500,"profit":false},{"date":"2022-12-31","value":-4598483200,"profit":false},{"date":"2023-12-31","value":-7341328700,"profit":false}] |
Pre-Tax Income | (48.28M) | (75.75M) | (71.65M) | (65.90M) | (28.24M) | [{"date":"2019-12-31","value":-4827931700,"profit":false},{"date":"2020-12-31","value":-7574854800,"profit":false},{"date":"2021-12-31","value":-7164761800,"profit":false},{"date":"2022-12-31","value":-6590395000,"profit":false},{"date":"2023-12-31","value":-2823900000,"profit":false}] |
Income Taxes | 8.77M | 11.86M | 12.81M | 19.28M | 8.16M | [{"date":"2019-12-31","value":45.47,"profit":true},{"date":"2020-12-31","value":61.5,"profit":true},{"date":"2021-12-31","value":66.42,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":42.35,"profit":true}] |
Income After Taxes | (57.05M) | (87.61M) | (84.45M) | (85.18M) | (36.40M) | [{"date":"2019-12-31","value":-5704537400,"profit":false},{"date":"2020-12-31","value":-8760508600,"profit":false},{"date":"2021-12-31","value":-8445287700,"profit":false},{"date":"2022-12-31","value":-8518332300,"profit":false},{"date":"2023-12-31","value":-3640310500,"profit":false}] |
Income From Continuous Operations | (48.28M) | (75.75M) | (71.65M) | (65.90M) | (22.83M) | [{"date":"2019-12-31","value":-4827931700,"profit":false},{"date":"2020-12-31","value":-7574854800,"profit":false},{"date":"2021-12-31","value":-7164761800,"profit":false},{"date":"2022-12-31","value":-6590395000,"profit":false},{"date":"2023-12-31","value":-2282615000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (57.05M) | (87.61M) | (84.45M) | (85.18M) | (28.24M) | [{"date":"2019-12-31","value":-5704537400,"profit":false},{"date":"2020-12-31","value":-8760508600,"profit":false},{"date":"2021-12-31","value":-8445287700,"profit":false},{"date":"2022-12-31","value":-8518332300,"profit":false},{"date":"2023-12-31","value":-2823900000,"profit":false}] |
EPS (Diluted) | (0.94) | (0.86) | (0.52) | (0.31) | (0.13) | [{"date":"2019-12-31","value":-94,"profit":false},{"date":"2020-12-31","value":-86,"profit":false},{"date":"2021-12-31","value":-52,"profit":false},{"date":"2022-12-31","value":-31,"profit":false},{"date":"2023-12-31","value":-13,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
ADMA | |
---|---|
Cash Ratio | 1.93 |
Current Ratio | 7.09 |
Quick Ratio | 3.26 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ADMA | |
---|---|
ROA (LTM) | 19.89% |
ROE (LTM) | 35.55% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ADMA | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.41 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.59 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ADMA | |
---|---|
Trailing PE | 68.85 |
Forward PE | 21.23 |
P/S (TTM) | 12.12 |
P/B | 19.03 |
Price/FCF | 191 |
EV/R | 11.59 |
EV/Ebitda | 44.91 |
PEG | NM |
ADMA Biologics Inc (ADMA) share price today is $18.59
Yes, Indians can buy shares of ADMA Biologics Inc (ADMA) on Vested. To buy ADMA Biologics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ADMA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of ADMA Biologics Inc (ADMA) via the Vested app. You can start investing in ADMA Biologics Inc (ADMA) with a minimum investment of $1.
You can invest in shares of ADMA Biologics Inc (ADMA) via Vested in three simple steps:
The 52-week high price of ADMA Biologics Inc (ADMA) is $23.64. The 52-week low price of ADMA Biologics Inc (ADMA) is $4.06.
The price-to-earnings (P/E) ratio of ADMA Biologics Inc (ADMA) is 69.1482
The price-to-book (P/B) ratio of ADMA Biologics Inc (ADMA) is 19.03
The dividend yield of ADMA Biologics Inc (ADMA) is 0.00%
The market capitalization of ADMA Biologics Inc (ADMA) is $4.41B
The stock symbol (or ticker) of ADMA Biologics Inc is ADMA